Advertisement
![Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px](/banner/iito-business-intelligence-20220401-650-100-promote-brand-to-decision-makers.jpg)
Product › Details
iPSC technology (induced pluripotent stem cell technology)
![]() |
Next higher product group | stem cell technology |
Record changed: 2022-05-17 |
Advertisement
![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
More documents for iPSC technology (induced pluripotent stem cell technology)
- [1] TreeFrog Therapeutics S.A.S.. (6/10/22). "Press Release: Umoja Biopharma and TreeFrog Therapeutics Announce Collaboration to Address Current Challenges Facing ex vivo Allogeneic Therapies in Immuno-oncology". Seattle, WA & Pessac....
- [2] Evotec SE. (5/17/22). "Press Release: Evotec and Sernova Announce Exclusive Strategic Partnership for iPSC-based Beta Cell Replacement Therapy to Advance a 'Functional Cure' for Diabetes". Hamburg & London, ON....
- [3] Quell Therapeutics Ltd.. (4/27/22). "Press Release: Quell Therapeutics and Cellistic Enter a Strategic Collaboration to Develop an iPSC-derived Allogeneic T-regulatory (Treg) Cell Therapy Platform". London & Gosselies....
- [4] Axol Bioscience Ltd.. (4/7/22). "Press Release: Axol Bioscience Raises £3.2 Million GBP (c. $4.2 Million USD)". Cambridge....
- [5] Ncardia Services B.V.. (2/24/22). "Press Release: Ncardia Appoints Andy Holt as Chief Commercial Officer". Leiden....
- [6] Evotec SE. (1/25/22). "Press Release: Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology". Hamburg....
- [7] DefiniGen Ltd.. (1/20/22). "Press Release: DefiniGen Appoints Dr Chris Kirton as Chief Executive Officer". Cambridge....
- [8] Ncardia. (11/16/21). "Press Release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings". Gosselies & New York, NY....
- [9] Clade Therapeutics. (11/3/21). "Press Release: Clade Therapeutics Raises $87 Million Series A Financing to Realize the Potential of Cell Therapy". Cambridge, MA....
- [10] Evotec SE. (10/8/21). "Press Release: Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include Novel Cell Type". Hamburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top